App-Quantinova.ai

Are we closing the Gender Gap in 2017? Vascular Complications following Common Femoral Arterial Access: Then and Now

Hari Bogabathina - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Impact of Clinical SYNTAX Score on 5 Years Clinical Outcomes in Patients Treated With Cobalt-Chromium Everolimus-Eluting Stent

Takashi Hiromasa - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Everolimus

Impact of Dual Antiplatelet Therapy on Device Thrombosis after Left Atrial Appendage Occlusion

Radoslaw Pracon - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

3-Year Results of Patients Undergoing Everolimus-eluting Bioresorbable Scaffolds Implantation During Daily Clinical Routine

Jens Wiebe - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Everolimus

Impact of Baseline Positive Coronary Artery Remodeling on 2-year Outcomes after IVUS-guided PCI: The ADAPT-DES IVUS Sub-Study

Song-Yi Kim - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Incidence, Predicting Factors, and Clinical Outcomes of Periprocedural Myocardial Infarction after Percutaneous Coronary Intervention of Chronic Total Occlusion in the new-generation drug-eluting stents era

Jin-Ho Kim - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results

Alexandre Abizaid - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 24-month Results from the DESolve PMCF Study

Holger Nef - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Everolimus

Types of Myocardial Infarction in Patients with Peripheral Artery Disease: Insights From EUCLID

Christoph Olivier - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Percutaneous coronary intervention in cardiac allograft vasculopathy: long term results from a single centre

Silvia Vilches-Soria - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Efficacy of the Indigo Aspiration Thrombectomy in the Extraction (XTRACT) of Peripheral Arterial Thromboembolism – Results from the PRISM Trial

George Adams - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Feasibility and Safety of Atherectomy in Endovascular Treatment of Infrainguinal Peripheral Arterial Disease via Retrograde Transpedal Approach

Apurva Patel - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Initial experience with magnesium bioabsorbable scaffold (Magmaris) in coronary de-novo lesions. Acute and mid-term result in multicenter Italian study

Stefano Galli - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Edoxaban versus Standard of Care and their Effects on Clinical Outcomes in Patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation – Rationale and Design of the ENVISAGE-TAVI AF Trial

Nicolas Van Mieghem - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Edoxaban

Five Years Clinical Outcome of the Cobalt-Chromium Everolimus-Eluting Stent in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis

Takashi Hiromasa - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Everolimus

Comparison of the clinical performance between COMBO and Xience stent at one year follow-up in all-comers patients

Deborah Kalkman - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Nine-Month Angiographic and 1-Year Clinical Outcomes of the RECOVERY Study: A Randomized Trial Evaluating the Safety and Efficacy of the Combo Bio-Engineered Sirolimus-Eluting Stent Versus the Nano Polymer-Free Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

Ling Tao - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

sirolimus

Traditional and genetic risk factors in young patients with myocardial infarction in Iraq

Ameen Mohammad - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Angiotensin II

Predictive Value of the Age, Creatinine, and Ejection Fraction (ACEF) Score in Patients with Acute Coronary Syndromes

Barbara Stähli - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

The comparison of usefulness of bioresorbable polymer-everolimus eluting stent with platinum chromium-everolimus eluting stent and everolimus-eluting stent in patients with the end-stage chronic kidney disease including hemodialysis

Takao Sato - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Everolimus

Filters

7277 Abstracts